|
Market Closed -
Toronto S.E.
15:59:59 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 7.920 CAD | -1.37% |
|
-15.65% | -26.46% |
| 09-01 | Profound Medical Appoints Richard Fabian as President | MT |
| 09-01 | Profound Medical Appoints Richard Fabian President | MT |
Company Valuation: Profound Medical Corp.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 296.2 | 302.3 | 266.8 | 324.3 | 390.9 | 289.3 | - | - |
| Change | - | 2.06% | -11.75% | 21.57% | 20.53% | -25.98% | - | - |
| Enterprise Value (EV) | 296.2 | 302.3 | 242.2 | 324.3 | 390.9 | 289.3 | 289.3 | 289.3 |
| Change | - | 2.06% | -19.89% | 33.92% | 20.53% | -25.98% | 0% | 0% |
| P/E | -7.5x | -7.64x | -6.11x | -6.77x | -5.57x | -6.6x | -9.69x | -77.3x |
| PBR | - | 4.21x | 5.65x | - | - | - | - | - |
| PEG | - | 24.18x | 1.48x | 0.6x | -0.3x | 0.2x | 0.3x | 0.9x |
| Capitalization / Revenue | 34x | 32.9x | 27.5x | 21.3x | 17.7x | 7.99x | 4.87x | 3.35x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 7.99x | 4.87x | 3.35x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -7.39x | -14.6x | 9.4x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -6.09x | -7.5x | -8.02x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.902 | -1.896 | -1.818 | -1.596 | -1.933 | -1.199 | -0.8172 | -0.1025 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 8.714 | 9.178 | 9.694 | 15.22 | 22.07 | 36.22 | 59.46 | 86.42 |
| EBITDA 1 | -26.89 | -32.64 | -32.39 | -42.1 | -48.27 | -39.16 | -19.78 | 30.78 |
| EBIT 1 | -38.41 | -40.67 | -38.53 | -47.12 | -56.57 | -47.54 | -38.57 | -36.1 |
| Net income 1 | -38.92 | -39.39 | -38.47 | -39.64 | -58.37 | -44.08 | -31.27 | -7.458 |
| Net Debt | - | - | -24.6 | - | - | - | - | - |
| Reference price 2 | 14.260 | 14.480 | 11.100 | 10.800 | 10.770 | 7.920 | 7.920 | 7.920 |
| Nbr of stocks (in thousands) | 20,769 | 20,876 | 24,033 | 30,028 | 36,293 | 36,533 | - | - |
| Announcement Date | 3/3/22 | 3/7/23 | 3/7/24 | 3/6/25 | 3/5/26 | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.7x | - | - | - | 211M | |
| 30.49x | 5.39x | 20.64x | 0.3% | 227B | |
| 34.28x | 6.21x | 19.68x | 0.69% | 143B | |
| 40.96x | 10.8x | 23.84x | -.--% | 134B | |
| 17x | 3.47x | 11.31x | -.--% | 65.29B | |
| 19.37x | 2.33x | 11.69x | 2.63% | 50.09B | |
| 33.79x | 6.76x | 21.37x | -.--% | 49.29B | |
| 28.59x | 5.68x | 19.28x | 0.7% | 41.39B | |
| 71.78x | 6.85x | 20.89x | -.--% | 40.28B | |
| 19.1x | 5.33x | 13.75x | 1.19% | 31.9B | |
| Average | 28.87x | 5.87x | 18.05x | 0.61% | 78.17B | |
| Weighted average by Cap. | 32.89x | 6.28x | 19.36x | 0.47% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PRN Stock
- Valuation Profound Medical Corp.
Select your edition
All financial news and data tailored to specific country editions
